The differences observed between cells with manipulation of ROR2 levels and control cells were evaluated using both Student's t-test and ANOVA.<h4>Results</h4>We describe that ROR2 contributes to tumor progression by enhancing the resistance of melanoma cells to both chemotherapeutic drugs and BH-3 mimetics. The gene discussed is ROR2; the disease is melanoma.